Literature DB >> 11547120

Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice.

P Sindhwani1, J A Hampton, M M Baig, R Keck, S H Selman.   

Abstract

PURPOSE: The development of an effective nontoxic intravesical agent that may be used immediately after bladder tumor resection to prevent the implantation of tumor cells would be a significant clinical advancement. We report the cytotoxic effects of curcumin on bladder tumor cell lines as well as its effects on the intravesical implantation of tumor cells in C3H mice.
MATERIALS AND METHODS: UMUC human and MBT-2 mouse bladder cancer lines were incubated with 0 to 100 microM. curcumin in dimethyl sulfoxide for 30 minutes and cell viability was determined by clonal assay. Additional culture dishes were incubated with curcumin and processed for electron microscopy. Using the C3H mice and the MBT2 tumor lines the effects of intravesical curcumin on tumor implantation after bladder injury was studied. The 10 group 1 mice served as nontreatment controls. In the 18 group 2 mice 30 minutes after tumor cell implantation 100 microM. curcumin in 0.1% dimethyl sulfoxide were instilled intravesically for 30 minutes. The 15 group 3 mice served as treatment controls with 0.1% dimethyl sulfoxide or culture medium instilled intravesically for 30 minutes. Animals were sacrificed 7 to 10 days after treatment and the bladder was subjected to histological analysis for tumor.
RESULTS: At the 100 microM. dose curcumin was completely lethal to the 2 cell lines on clonal growth assay. Electron microscopy revealed apoptotic bodies after curcumin administration. The tumor implantation rate was 16.7% (3 of 18 mice) in curcumin treated bladders and 73% (11 of 15) in the vehicle control group.
CONCLUSIONS: At the 100 microm. concentration curcumin is a potent cytotoxic agent against the MBT and UMUC bladder tumor cell lines. In addition, curcumin effectively inhibits tumor implantation and growth in this murine bladder tumor model.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11547120

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

Review 1.  Discovery of curcumin, a component of golden spice, and its miraculous biological activities.

Authors:  Subash C Gupta; Sridevi Patchva; Wonil Koh; Bharat B Aggarwal
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-03       Impact factor: 2.557

2.  Sensitivity of bladder cancer cells to curcumin and its derivatives depends on the extracellular matrix.

Authors:  Paul J Hauser; Zhiyong Han; Puneet Sindhwani; Robert E Hurst
Journal:  Anticancer Res       Date:  2007 Mar-Apr       Impact factor: 2.480

Review 3.  Curcumin: from ancient medicine to current clinical trials.

Authors:  H Hatcher; R Planalp; J Cho; F M Torti; S V Torti
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

4.  Curcumin cytotoxicity is enhanced by PTEN disruption in colorectal cancer cells.

Authors:  Lin Chen; Wen-Feng Li; Hong-Xiao Wang; Hai-Na Zhao; Jia-Jia Tang; Chang-Jie Wu; Li-Ting Lu; Wan-Qin Liao; Xin-Cheng Lu
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

5.  Antioncogenic effects of transient receptor potential vanilloid 1 in the progression of transitional urothelial cancer of human bladder.

Authors:  Giorgio Santoni; Sara Caprodossi; Valerio Farfariello; Sonia Liberati; Angela Gismondi; Consuelo Amantini
Journal:  ISRN Urol       Date:  2012-02-06

6.  Tumor establishment features of orthotopic murine bladder cancer models.

Authors:  Jin Seok Lee; Min Ho Bae; Sung Ho Choi; Sang Hun Lee; Young Sam Cho; Heung Jae Park; Chil Hun Kwon; Kwan Joong Joo
Journal:  Korean J Urol       Date:  2012-06-19

Review 7.  Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways.

Authors:  Arshad H Rahmani; Mohammad A Al Zohairy; Salah M Aly; Masood A Khan
Journal:  Biomed Res Int       Date:  2014-09-10       Impact factor: 3.411

8.  Concentration- Dependent Effects of Curcumin on 5-Fluorouracil Efficacy in Bladder Cancer Cells

Authors:  Noushin Afsharmoghadam; Zahra Haghighatian; Hamid Mazdak; Nooshin Mirkheshti; Razieh Mehrabi Koushki; Sayyed Ali Alavi
Journal:  Asian Pac J Cancer Prev       Date:  2017-12-28

9.  Lumbrokinase/paclitaxel nanoparticle complex: potential therapeutic applications in bladder cancer.

Authors:  Bo Hu; Ying Yan; Fei Tong; Long Xu; Jia Zhu; Guangtao Xu; Ruilin Shen
Journal:  Int J Nanomedicine       Date:  2018-06-26

10.  A pilot study on intravesical administration of curcumin for cystitis glandularis.

Authors:  Qiong Lu; Fen Jiang; Ran Xu; Xiao-Kun Zhao; Zhao-Hui Zhong; Lei Zhang; Hong-Yi Jiang; Lu Yi; Yi Hou; Xuan Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-22       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.